Xiamen Innovax Biotech Co., Ltd. ("Innovax") is a global biotechnology leader specializing in innovative vaccines. Powered by its proprietary E. coli-expressed Virus-Like Particle (VLP) platform, Innovax has successfully commercialized groundbreaking products—including the world’s first and only hepatitis E vaccine (Hecolin), as well as Cecolin (bivalent) and its 9-valent HPV vaccines. Innovax continues to contribute pivotal Chinese innovations to global public health.
As a pharmaceutical powerhouse expanding its footprint worldwide, Innovax faced a dual challenge with its previous digital presence:
High Information Density vs. User Friction: Translating complex virology, clinical pipelines, and global compliance data into an accessible, intuitive web hierarchy for both clinical partners and global investors.
Brand Positioning Deficit: The legacy digital interface lagged behind Innovax’s status as a world-class vaccine pioneer, lacking the prestige, international aesthetic, and high-trust experience expected by overseas health authorities.
To elevate Innovax’s global digital authority, SUMAART Design delivered an end-to-end custom web transformation:
We redesigned the information architecture from the ground up. By reorganizing complex clinical pipelines and core technology platforms (like the VLP system) into a structured, visual storytelling layout, we transformed heavy academic literature into a clean, modern digital journey.
Reflecting Innovax’s dual identity—scientific rigor and global public welfare—we developed a refined visual identity system. Featuring a high-contrast corporate grid, custom-rendered 3D medical iconography, and restrained typography, the new site establishes immediate credibility with global stakeholders.
We built a dynamic, interactive R&D Pipeline showcase alongside a dedicated international compliance center. Investors and global health organizations can now navigate clinical trial milestones and regulatory documentation seamlessly across all breakpoints.
To guarantee zero-friction browsing across overseas markets, we engineered a lightweight frontend architecture using asynchronous asset loading and optimized media rendering. Complex visual layouts and interactive modules load effortlessly with minimal latency.
The Impact:
The new digital flagship positions Innovax not just as a manufacturing leader, but as a world-class innovator driving the future of global immunization.
